Visiopharm
ExitedMedical image analysis software
Visiopharm has raised €13M across 1 funding round from 2 investors, most recently a round in Aug 2018. Based in Denmark; founded 2001; active in Healthtech. Acquired by Grundium in 2026. Data as of 4 Nov 2026.
Total raised
€13M
€12,736,633
Funding rounds
1
Investors
2
distinct backers
Active since
2018-08
latest 2018-08
Funding by year
EUR raised per yearVisiopharm — funding by year — interactive chart.
Data table
| Visiopharm — funding by year | |
|---|---|
| 2018 | €13M |
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2018-08-23 | Other | €13M | ATP,Vækstfonden | View deal → |
Exit
Investors
2Related news
Similar companies
same sector, similar size- AFYX Therapeutics€11MDenmark · Healthtech
- RSP Systems€10MDenmark · Healthtech
- Biosyntia€16MDenmark · Healthtech
- Sekoia€16MDenmark · Healthtech
- Doctena€13MLuxembourg · Healthtech
- Doc+€12MRussia · Healthtech
Global coverage: FundingData